Eversana Executive and Leadership Team

Faruk Capan, the Chief Innovation Officer & Chief Executive Officer, EVERSANA INTOUCH at Eversana, spearheads the companys strategic direction for innovation and leads the Eversana Intouch division. Driving the development of novel solutions and digital technologies, Capan ensures Eversana remains at the forefront of commercial services for the life sciences industry. This dual role involves fostering a culture of continuous improvement and exploring new avenues to enhance patient outcomes and client success. By championing cutting-edge approaches, Faruk Capan directly supports the delivery of integrated, end-to-end services that address the evolving needs of pharmaceutical and biotechnology companies. The Chief Innovation Officer & Chief Executive Officer, EVERSANA INTOUCH position is pivotal in shaping the future of healthcare commercialization, leveraging data analytics and digital platforms to create sustainable value. Capan's leadership guides the organization in adapting to market dynamics and delivering transformative solutions.

Andrew McCormick, the Chief Operating Officer, Eversana Intouch at Eversana, manages the day-to-day operational execution of the companys integrated commercial services, with a specific focus on the Eversana Intouch division. Overseeing a broad spectrum of operational functions, McCormick ensures the seamless delivery of services that support pharmaceutical and biotechnology clients throughout their product lifecycles. This executive position involves optimizing processes to enhance efficiency and client satisfaction across market access, patient services, and commercialization efforts. By driving operational improvements, Andrew McCormick directly contributes to the companys mission of improving patient outcomes and enabling client success in a complex healthcare landscape. The Chief Operating Officer role requires a deep understanding of the life sciences industrys unique challenges, enabling McCormick to implement cohesive strategies that align with Eversanas integrated platform model. His leadership ensures that operational capabilities consistently meet and exceed client expectations.

Danny Williams, the President, Channel Management at Eversana, leads the strategic development and execution of the companys channel management services. Overseeing all aspects of distribution, partnerships, and supply chain logistics, Williams ensures efficient and effective delivery of life sciences products to market. This executive role is critical for optimizing Eversanas integrated commercial services, supporting clients from product launch through ongoing market presence. By enhancing channel effectiveness, Danny Williams directly contributes to improving patient access to therapies and enabling client success in a competitive healthcare landscape. The President, Channel Management position requires a deep understanding of market dynamics and regulatory requirements to ensure seamless operations. Williams' leadership drives the companys ability to provide comprehensive solutions that meet the evolving needs of the industry.

Jennifer Norton, the President, Market Access & Value at Eversana, leads the strategic initiatives focused on ensuring patient access to therapies and demonstrating product value. Overseeing market access, pricing, and reimbursement strategies, Norton drives the companys commitment to improving patient outcomes and enabling client success within the life sciences industry. This executive position is pivotal in navigating the complexities of healthcare economics and payer relations. By developing innovative value-based solutions, Jennifer Norton directly supports pharmaceutical and biotechnology companies in achieving sustainable commercialization. The President, Market Access & Value role requires deep expertise in health economics and outcomes research to effectively position products in the market. Norton's leadership ensures that Eversanas integrated services provide clients with the critical support needed to demonstrate product value and secure market adoption.

Gregory Skalicky, the President, EVERSANA at Eversana, holds a key leadership position driving the companys overall commercial strategy and operational execution. Overseeing a broad portfolio of integrated services, Skalicky ensures that Eversana effectively supports pharmaceutical and biotechnology clients throughout their product lifecycles, from development to post-market. This executive role is central to achieving the companys mission of improving patient outcomes and enabling client success in the complex life sciences landscape. By fostering collaboration and driving strategic initiatives, Gregory Skalicky directly contributes to the delivery of end-to-end solutions that address critical industry challenges. The President, EVERSANA position requires a comprehensive understanding of market dynamics and a commitment to innovation. Skalicky's leadership ensures that Eversana consistently provides high-value services that enhance market access, patient engagement, and commercial performance.

Mark Halloran, the Senior Vice President, Chief Information Officer at Eversana, directs the companys overarching technology strategy and information systems. Overseeing all digital infrastructure, Halloran ensures the secure and efficient operation of platforms supporting Eversanas integrated commercial services for the life sciences industry. This leadership role involves architecting scalable IT solutions that enhance client engagement and streamline product lifecycle management. By aligning technology investments with business objectives, Mark Halloran drives operational excellence and supports the delivery of end-to-end solutions from early-stage strategy through post-market support. The Chief Information Officer role is critical in maintaining data integrity and advancing the companys digital transformation initiatives, ensuring Eversana remains at the forefront of technological innovation within the healthcare sector. Halloran's strategic vision enables the organization to provide robust data analytics and digital solutions that improve patient outcomes and client success.

Fred Skinner, the Chief Human Resources Officer at Eversana, leads all aspects of human capital management and organizational development. Overseeing talent acquisition, employee engagement, and HR strategy, Skinner ensures that Eversana cultivates a high-performing workforce capable of delivering integrated commercial services to the life sciences industry. This critical role involves developing and implementing policies that support the companys mission of improving patient outcomes and enabling client success. By fostering a culture of collaboration and innovation, Fred Skinner directly impacts the effectiveness of Eversanas end-to-end solutions, from early-stage strategy to post-market support. The Chief Human Resources Officer is instrumental in aligning HR initiatives with the companys overarching business objectives, ensuring that Eversana attracts, retains, and develops top talent. Skinner's leadership ensures the organization has the skilled personnel necessary to navigate the complexities of the healthcare environment and drive sustainable growth.

John Wollman, the Executive Vice President & Chief Technology Officer at Eversana, directs the companys technological infrastructure and development initiatives. Overseeing the strategic implementation of advanced technology solutions, Wollman ensures that Eversana provides robust digital platforms and data analytics capabilities to support the life sciences industry. This leadership position is crucial for enhancing the companys integrated commercial services, enabling clients to navigate product lifecycles effectively from development through post-market support. By driving technological innovation, John Wollman directly contributes to improving patient outcomes and achieving client success in a complex healthcare ecosystem. The Chief Technology Officer role involves architecting scalable systems that support the companys mission and operational model, ensuring data security and operational efficiency. Wollman's expertise is vital in maintaining Eversanas competitive edge through advanced technological integration.

Teng Fei, the Chief Medical Officer at Eversana, provides critical medical and scientific expertise to guide the companys commercial services for the life sciences industry. Overseeing clinical strategy and ensuring the scientific integrity of client solutions, Fei plays a key role in enhancing patient outcomes and supporting client success. This executive position involves translating complex medical insights into actionable commercial strategies, aligning with Eversanas mission to improve healthcare delivery. By offering medical leadership, Teng Fei directly contributes to the development of effective market access, pricing, and patient support programs. The Chief Medical Officer role is essential for ensuring that Eversanas integrated platform addresses the nuanced medical and regulatory considerations inherent in the pharmaceutical and biotechnology sectors. Fei's guidance ensures that all services are grounded in sound medical science and patient-centric principles.

Monica Avram, the Executive Vice President & Chief Legal Officer at Eversana, provides comprehensive legal counsel and oversees all legal affairs for the organization. Directing legal strategy and ensuring compliance across all commercial services for the life sciences industry, Avram safeguards the company's operations and client interests. This critical role involves navigating complex regulatory environments and mitigating legal risks associated with product lifecycles. By ensuring adherence to all applicable laws and regulations, Monica Avram directly supports Eversanas mission to improve patient outcomes and enable client success. The Chief Legal Officer position is fundamental to maintaining the integrity and trustworthiness of Eversanas integrated platform. Avram's expertise is essential in managing contracts, intellectual property, and corporate governance, ensuring the company operates ethically and effectively within the global healthcare sector.